NCT06916052

Brief Summary

The goal of this clinical trial investigation with device is to to analyze the use of the Caaring® digital platform for the preparation and follow-up of scheduled colonoscopy. Colonoscopy is a difficult procedure, and it is estimated that bowel preparation is inadequate in about 25% of patients. The main question it aims to answer is if the use of a digital platform (Caaring®) could be an effective tool for reducing the percentage of inadequate bowel preparations in patients with a scheduled colonoscopy. To this end, the application will provide precise instructions to patients. A prospective, single-center, observational study with software device: The recruitment phase is expected to last two months. Patients will be followed for one month after the colonoscopy and 14 days prior to it. Additionally, measuring patient experience and monitoring adverse effects after a colonoscopy are crucial to improving the safety of colonoscopies and the quality of healthcare, promoting higher quality colonoscopy services. For that to happen, participants must have sufficient technological skills to use a smartphone.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
225

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2025

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

March 31, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

March 31, 2025

Last Update Submit

June 13, 2025

Conditions

Keywords

Colonoscopy preparationDigital PlatformCaaringOutpatient colonoscopyDTxPatient-reported DataReal World DataRWDPROMsDigital Health

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients scheduled colonoscopy who have an adequate bowel preparation.

    Percentage of colonoscopies with adequate bowel preparation defined as having a total Boston Bowel Preparation Scale (BBPS) score greater than or equal of 6 and BBPS score for per colon segment ≥2.

    Day 0, (Colonoscopy Day)

Secondary Outcomes (16)

  • Active Patient Rate

    Day -14 (14 days before the colonoscopy)

  • Patients with section completed: Treatments

    Day -14 (14 days before the colonoscopy)

  • Patients with section completed: Pick up the bowel preparation

    Day -10 (10 days before colonoscopy)

  • Patients with section completed: Colonoscopy Preparation Solution (laxative).

    Day 2 (2 days after colonoscopy)

  • Patients with section completed: Procedure satisfaction questionnaire

    Day 3 (3 days after colonoscopy)

  • +11 more secondary outcomes

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients from the Hospital Clínic in Barcelona diagnosed with a scheduled colonoscopy who meet the selection criteria and sign the informed consent will be included.

You may qualify if:

  • Age 18 or older.
  • Signed informed consent.
  • Patients scheduled for outpatient colonoscopy.
  • Patients able to complete the study questionnaires.
  • Patients who regularly use a smartphone

You may not qualify if:

  • Patients enrolled in the population-based colorectal cancer screening program with a positive fecal occult blood test.
  • Minors or elderly patients (over 80 years of age).
  • Patients with prior colorectal surgery.
  • Patients who, in the opinion of the researcher, will not be able to commit to follow-up or lack adequate technological skills.
  • Inability to provide adequate informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínic de Barcelona

Barcelona, Barcelona, 08036, Spain

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2025

First Posted

April 8, 2025

Study Start

March 13, 2025

Primary Completion

July 1, 2025

Study Completion

August 1, 2025

Last Updated

June 15, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations